Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-25 @ 2:28 AM
NCT ID:
NCT02272634
Eligibility Criteria:
Inclusion Criteria:
* Adult males and/or females, 30 to 85 years of age (inclusive).
* History of COPD for at least 12 months prior to screening.
* Diagnosed with COPD as defined by the American Thoracic Society (ATS)/European Respiratory Society (ERS) guidelines with symptoms compatible with COPD for at least 12 months prior to screening.
* Classified as moderate to severe COPD based on the current severity classification GOLD Stage 2-3 disease in terms of post-bronchodilator spirometry at screening
* etc.
Exclusion Criteria:
* History of life-threatening COPD including respiratory arrest, intensive care unit admission and/or requiring intubation.
* History of more than 2 hospitalizations for COPD within 12 months prior to screening.
* Presentation of an acute exacerbation of COPD that will be associated with increase sputum volume or change in sputum color within 4 weeks before Day 1 of the Run-in Period.
* Evidence of pulmonary heart disease, or clinically significant pulmonary hypertension.
* etc.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
85 Years
Study:
NCT02272634
Study Brief:
Protocol Section:
NCT02272634